Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-β-lactamases in Myanmar.

Tohya M, Tada T, Watanabe S, Kuwahara-Arai K, Zin KN, Zaw NN, Aung MY, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475-19. doi: 10.1128/AAC.00475-19. [Epub ahead of print]

PMID:
31138570
2.

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.

Hishinuma T, Tada T, Uchida H, Shimojima M, Kirikae T.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00124-19. doi: 10.1128/AAC.00124-19. Print 2019 Jun.

PMID:
30962328
3.

Pseudomonas asiatica sp. nov., isolated from hospitalized patients in Japan and Myanmar.

Tohya M, Watanabe S, Teramoto K, Uechi K, Tada T, Kuwahara-Arai K, Kinjo T, Maeda S, Nakasone I, Zaw NN, Mya S, Zan KN, Tin HH, Fujita J, Kirikae T.

Int J Syst Evol Microbiol. 2019 May;69(5):1361-1368. doi: 10.1099/ijsem.0.003316. Epub 2019 Feb 27.

PMID:
30810522
4.

Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Tada T, Hishinuma T, Watanabe S, Uchida H, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02397-18. doi: 10.1128/AAC.02397-18. Print 2019 May.

PMID:
30803967
5.

Emergence in Japan of an isolate of Klebsiella pneumoniae co-harbouring blaKPC-2 and rmtB.

Uchida H, Tada T, Tohya M, Sugahara Y, Kato A, Miyairi I, Kirikae T.

J Glob Antimicrob Resist. 2018 Dec 13;17:157-159. doi: 10.1016/j.jgar.2018.11.026. [Epub ahead of print]

PMID:
30553930
6.

An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens.

Uechi K, Tada T, Kuwahara-Arai K, Sekiguchi JI, Yanagisawa I, Tome T, Nakasone I, Maeda S, Mya S, Zan KN, Tin HH, Kirikae T, Fujita J.

J Med Microbiol. 2019 Feb;68(2):124-131. doi: 10.1099/jmm.0.000888. Epub 2018 Dec 10.

PMID:
30526741
7.

Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS).

Matsuo M, Hiramatsu M, Singh M, Sasaki T, Hishinuma T, Yamamoto N, Morimoto Y, Kirikae T, Hiramatsu K.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02019-18. doi: 10.1128/AAC.02019-18. Print 2019 Feb.

PMID:
30509938
8.

Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235.

Hishinuma T, Tada T, Kuwahara-Arai K, Yamamoto N, Shimojima M, Kirikae T.

PLoS One. 2018 Nov 19;13(11):e0207134. doi: 10.1371/journal.pone.0207134. eCollection 2018.

9.

Pathogenicity Induced by Invasive Infection of Streptococcus dysgalactiae subsp. equisimilis in a Mouse Model of Diabetes.

Ogura K, Okumura K, Shimizu Y, Kirikae T, Miyoshi-Akiyama T.

Front Microbiol. 2018 Sep 21;9:2128. doi: 10.3389/fmicb.2018.02128. eCollection 2018.

10.

A carbapenem-resistant clinical isolate of Aeromonas hydrophila in Japan harbouring an acquired gene encoding GES-24 β-lactamase.

Uechi K, Tada T, Sawachi Y, Hishinuma T, Takaesu R, Nakama M, Nakasone I, Kirikae T, Fujita J.

J Med Microbiol. 2018 Nov;67(11):1535-1537. doi: 10.1099/jmm.0.000842. Epub 2018 Oct 5.

PMID:
30289383
11.

Emergence of a carbapenem-resistant and colistin-heteroresistant Enterobacter cloacae clinical isolate in Japan.

Uechi K, Tada T, Shimada K, Nakasone I, Kirikae T, Fujita J.

J Infect Chemother. 2019 Apr;25(4):285-288. doi: 10.1016/j.jiac.2018.09.004. Epub 2018 Sep 29.

PMID:
30279112
12.

Emergence of IncX4 plasmids encoding mcr-1 in a clinical isolate of Klebsiella pneumoniae in Japan.

Tada T, Uechi K, Nakasone I, Nakamatsu M, Satou K, Hirano T, Kirikae T, Fujita J.

Int J Infect Dis. 2018 Oct;75:98-100. doi: 10.1016/j.ijid.2018.08.011. Epub 2018 Aug 24.

13.

A clinical isolate of Escherichia coli co-harbouring mcr-1 and blaNDM-5 in Japan.

Uchida H, Tada T, Sugahara Y, Kato A, Miyairi I, Kirikae T.

J Med Microbiol. 2018 Aug;67(8):1047-1049. doi: 10.1099/jmm.0.000793. Epub 2018 Jul 4.

PMID:
29972350
14.

Instability of the 16S rRNA methyltransferase-encoding npmA gene: why have bacterial cells possessing npmA not spread despite their high and broad resistance to aminoglycosides?

Ishizaki Y, Shibuya Y, Hayashi C, Inoue K, Kirikae T, Tada T, Miyoshi-Akiyama T, Igarashi M.

J Antibiot (Tokyo). 2018 Sep;71(9):798-807. doi: 10.1038/s41429-018-0070-y. Epub 2018 Jun 8.

PMID:
29884863
15.

A hemin auxotrophic Enterobacter cloacae clinical isolate with increased resistance to carbapenems and aminoglycosides.

Tada T, Uechi K, Nakasone I, Miyazato Z, Shinzato T, Shimada K, Tsuchiya M, Kirikae T, Fujita J.

J Med Microbiol. 2018 Jan;67(1):29-32. doi: 10.1099/jmm.0.000655. Epub 2017 Dec 5.

PMID:
29205135
16.

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa.

Miyoshi-Akiyama T, Tada T, Ohmagari N, Viet Hung N, Tharavichitkul P, Pokhrel BM, Gniadkowski M, Shimojima M, Kirikae T.

Genome Biol Evol. 2017 Dec 1;9(12):3238-3245. doi: 10.1093/gbe/evx243.

17.

Comparison of the clinical and microbiological characteristics of Campylobacter and Helicobacter bacteremia: the importance of time to blood culture positivity using the BACTEC blood culture systems.

Yamamoto K, Hayakawa K, Nagashima M, Shimada K, Kutsuna S, Takeshita N, Kato Y, Kanagawa S, Yamada K, Mezaki K, Kirikae T, Ohmagari N.

BMC Res Notes. 2017 Nov 28;10(1):634. doi: 10.1186/s13104-017-2981-2.

18.

A New Variant of 16S rRNA Methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar.

Tada T, Shimada K, Mya S, Zan KN, Kuwahara K, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01806-17. doi: 10.1128/AAC.01806-17. Print 2018 Jan. No abstract available.

19.

Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan.

Uechi K, Tada T, Shimada K, Nakasone I, Sonozaki T, Kirikae T, Fujita J.

J Infect Chemother. 2018 Jan;24(1):68-70. doi: 10.1016/j.jiac.2017.09.006. Epub 2017 Oct 21.

PMID:
29066218
20.

Emergence of Various NDM-Type-Metallo-β-Lactamase-Producing Escherichia coli Clinical Isolates in Nepal.

Shrestha B, Tada T, Shimada K, Shrestha S, Ohara H, Pokhrel BM, Sherchand JB, Kirikae T.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01425-17. doi: 10.1128/AAC.01425-17. Print 2017 Dec.

21.

A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.

Uechi K, Tada T, Shimada K, Kuwahara-Arai K, Arakaki M, Tome T, Nakasone I, Maeda S, Kirikae T, Fujita J.

J Clin Microbiol. 2017 Dec;55(12):3405-3410. doi: 10.1128/JCM.00893-17. Epub 2017 Sep 27.

22.

Emergence of a colistin-resistant Escherichia coli clinical isolate harboring mcr-1 in Japan.

Tada T, Uechi K, Nakasone I, Shimada K, Nakamatsu M, Kirikae T, Fujita J.

Int J Infect Dis. 2017 Oct;63:21-22. doi: 10.1016/j.ijid.2017.07.023. Epub 2017 Aug 2.

23.

Emergence of colistin-resistant Escherichia coli clinical isolates harboring mcr-1 in Vietnam.

Tada T, Nhung PH, Shimada K, Tsuchiya M, Phuong DM, Anh NQ, Ohmagari N, Kirikae T.

Int J Infect Dis. 2017 Oct;63:72-73. doi: 10.1016/j.ijid.2017.07.003. Epub 2017 Jul 10.

24.

Complete Genome Sequence and Comparative Genomics of a Streptococcus pyogenes emm3 Strain M3-b isolated from a Japanese Patient with Streptococcal Toxic Shock Syndrome.

Ogura K, Watanabe S, Kirikae T, Miyoshi-Akiyama T.

J Genomics. 2017 Jul 1;5:71-74. doi: 10.7150/jgen.20915. eCollection 2017.

25.

Pseudomonas aeruginosa Clinical Isolates in Nepal Coproducing Metallo-β-Lactamases and 16S rRNA Methyltransferases.

Tada T, Shimada K, Satou K, Hirano T, Pokhrel BM, Sherchand JB, Kirikae T.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00694-17. doi: 10.1128/AAC.00694-17. Print 2017 Sep.

26.

Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam.

Tada T, Tsuchiya M, Shimada K, Nga TTT, Thu LTA, Phu TT, Ohmagari N, Kirikae T.

BMC Infect Dis. 2017 Jul 4;17(1):467. doi: 10.1186/s12879-017-2570-y.

27.

Correction for Miyoshi-Akiyama et al., "Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan".

Miyoshi-Akiyama T, Sherchan JB, Doi Y, Nagamatsu M, Sherchand JB, Tandukar S, Ohmagari N, Kirikae T, Ohara H, Hayakawa K.

mSphere. 2017 May 24;2(3). pii: e00136-17. doi: 10.1128/mSphere.00136-17. eCollection 2017 May-Jun.

28.

Genetic diversity of Mycobacterium tuberculosis isolates from Tochigi prefecture, a local region of Japan.

Mizukoshi F, Miyoshi-Akiyama T, Iwai H, Suzuki T, Kiritani R, Kirikae T, Funatogawa K.

BMC Infect Dis. 2017 May 25;17(1):365. doi: 10.1186/s12879-017-2457-y.

29.

PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.

Tada T, Shrestha S, Shimada K, Ohara H, Sherchand JB, Pokhrel BM, Kirikae T.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02300-16. doi: 10.1128/AAC.02300-16. Print 2017 Mar.

30.

Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.

Shrestha S, Tada T, Shrestha B, Kirikae T, Ohara H, Rijal BP, Pokhrel BM, Sherchand JB.

J Nepal Health Res Counc. 2016 May;14(33):72-76.

PMID:
27885285
31.

Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan.

Miyoshi-Akiyama T, Sherchan JB, Doi Y, Nagamatsu M, Sherchand JB, Tandukar S, Ohmagari N, Kirikae T, Ohara H, Hayakawa K.

mSphere. 2016 Oct 26;1(5). pii: e00289-16. eCollection 2016 Sep-Oct. Erratum in: mSphere. 2017 May 24;2(3):.

32.

High rate of multidrug-resistant organism colonization among patients hospitalized overseas highlights the need for preemptive infection control.

Hayakawa K, Mezaki K, Sugiki Y, Nagamatsu M, Miyoshi-Akiyama T, Kirikae T, Kutsuna S, Takeshita N, Yamamoto K, Katanami Y, Ohmagari N.

Am J Infect Control. 2016 Nov 1;44(11):e257-e259. doi: 10.1016/j.ajic.2016.06.040.

PMID:
27810070
33.

Peroxiredoxin 1 Contributes to Host Defenses against Mycobacterium tuberculosis.

Matsumura K, Iwai H, Kato-Miyazawa M, Kirikae F, Zhao J, Yanagawa T, Ishii T, Miyoshi-Akiyama T, Funatogawa K, Kirikae T.

J Immunol. 2016 Oct 15;197(8):3233-3244. Epub 2016 Sep 7.

34.

Multidrug-Resistant Sequence Type 235 Pseudomonas aeruginosa Clinical Isolates Producing IMP-26 with Increased Carbapenem-Hydrolyzing Activities in Vietnam.

Tada T, Nhung PH, Miyoshi-Akiyama T, Shimada K, Tsuchiya M, Phuong DM, Anh NQ, Ohmagari N, Kirikae T.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6853-6858. doi: 10.1128/AAC.01177-16. Print 2016 Nov.

35.

A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis.

Watanabe S, Matsumura K, Iwai H, Funatogawa K, Haishima Y, Fukui C, Okumura K, Kato-Miyazawa M, Hashimoto M, Teramoto K, Kirikae F, Miyoshi-Akiyama T, Kirikae T.

Infect Immun. 2016 Jul 21;84(8):2264-2273. doi: 10.1128/IAI.00417-16. Print 2016 Aug.

36.

A Carbapenem-Resistant Pseudomonas aeruginosa Isolate Harboring Two Copies of blaIMP-34 Encoding a Metallo-β-Lactamase.

Tada T, Miyoshi-Akiyama T, Shimada K, Shiroma A, Nakano K, Teruya K, Satou K, Hirano T, Shimojima M, Kirikae T.

PLoS One. 2016 Apr 7;11(4):e0149385. doi: 10.1371/journal.pone.0149385. eCollection 2016.

37.

Phenotypic Characterization of Multidrug-resistant Escherichia Coli with Special Reference to Extended-spectrum-beta-lactamases and Metallo-beta-lactamases in a Tertiary Care Center.

Shrestha B, Shrestha S, Mishra SK, Kattel HP, Tada T, Ohara H, Kirikae T, Rijal BP, Sherchand JB, Pokhrel BM.

JNMA J Nepal Med Assoc. 2015 Apr-Jun;53(198):89-95.

PMID:
26994027
38.

CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): A publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates.

Iwai H, Kato-Miyazawa M, Kirikae T, Miyoshi-Akiyama T.

Tuberculosis (Edinb). 2015 Dec;95(6):843-844. doi: 10.1016/j.tube.2015.09.002. Epub 2015 Oct 19. No abstract available.

PMID:
26542225
39.

Dissemination of clonal complex 2 Acinetobacter baumannii strains co-producing carbapenemases and 16S rRNA methylase ArmA in Vietnam.

Tada T, Miyoshi-Akiyama T, Shimada K, Nga TT, Thu le TA, Son NT, Ohmagari N, Kirikae T.

BMC Infect Dis. 2015 Oct 15;15:433. doi: 10.1186/s12879-015-1171-x.

40.

Development and evaluation of immunochromatography to detect Gram-negative bacteria producing ArmA 16S rRNA methylase responsible for aminoglycoside resistance.

Oshiro S, Tada T, Kameoka Y, Suzuki K, Ohmagari N, Miyoshi-Akiyama T, Kirikae T.

J Microbiol Methods. 2015 Nov;118:159-63. doi: 10.1016/j.mimet.2015.09.005. Epub 2015 Sep 14.

PMID:
26381663
41.

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.

Shrestha S, Tada T, Miyoshi-Akiyama T, Ohara H, Shimada K, Satou K, Teruya K, Nakano K, Shiroma A, Sherchand JB, Rijal BP, Hirano T, Kirikae T, Pokhrel BM.

Int J Antimicrob Agents. 2015 Nov;46(5):526-31. doi: 10.1016/j.ijantimicag.2015.07.012. Epub 2015 Aug 28.

PMID:
26362951
42.

IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.

Tada T, Nhung PH, Miyoshi-Akiyama T, Shimada K, Phuong DM, Anh NQ, Ohmagari N, Kirikae T.

Antimicrob Agents Chemother. 2015 Nov;59(11):7090-3. doi: 10.1128/AAC.01611-15. Epub 2015 Aug 17.

43.

A Novel 6'-N-Aminoglycoside Acetyltransferase, AAC(6')-Ial, from a Clinical Isolate of Serratia marcescens.

Tada T, Miyoshi-Akiyama T, Shimada K, Dahal RK, Mishra SK, Ohara H, Kirikae T, Pokhrel BM.

Microb Drug Resist. 2016 Mar;22(2):103-8. doi: 10.1089/mdr.2015.0126. Epub 2015 Aug 13.

PMID:
26270859
44.

Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal.

Shrestha B, Tada T, Miyoshi-Akiyama T, Shimada K, Ohara H, Kirikae T, Pokhrel BM.

Antimicrob Agents Chemother. 2015 Sep;59(9):5847-50. doi: 10.1128/AAC.00332-15. Epub 2015 Jul 13.

45.

Evaluation of the Etest method for detecting colistin susceptibility of multidrug-resistant Gram-negative isolates in Vietnam.

Nhung PH, Miyoshi-Akiyama T, Phuong DM, Shimada K, Anh NQ, Binh NG, Thanh do V, Ohmagari N, Kirikae T.

J Infect Chemother. 2015 Aug;21(8):617-9. doi: 10.1016/j.jiac.2015.04.002. Epub 2015 Apr 18.

PMID:
25960156
46.

Construction of a virtual Mycobacterium tuberculosis consensus genome and its application to data from a next generation sequencer.

Okumura K, Kato M, Kirikae T, Kayano M, Miyoshi-Akiyama T.

BMC Genomics. 2015 Mar 20;16:218. doi: 10.1186/s12864-015-1368-9.

47.

MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection.

Iwai H, Funatogawa K, Matsumura K, Kato-Miyazawa M, Kirikae F, Kiga K, Sasakawa C, Miyoshi-Akiyama T, Kirikae T.

Tuberculosis (Edinb). 2015 May;95(3):246-50. doi: 10.1016/j.tube.2015.03.006. Epub 2015 Mar 21.

PMID:
25846955
48.

Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.

Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S.

Antimicrob Agents Chemother. 2015;59(6):3424-32. doi: 10.1128/AAC.00270-15. Epub 2015 Mar 30.

49.

Genetic diversity of Mycobacterium tuberculosis isolates from foreign-born and Japan-born residents in Tokyo.

Kato-Miyazawa M, Miyoshi-Akiyama T, Kanno Y, Takasaki J, Kirikae T, Kobayashi N.

Clin Microbiol Infect. 2015 Mar;21(3):248.e1-8. doi: 10.1016/j.cmi.2014.09.013. Epub 2014 Oct 13.

50.

Antimicrobial photodynamic therapy suppresses dental plaque formation in healthy adults: a randomized controlled clinical trial.

Ichinose-Tsuno A, Aoki A, Takeuchi Y, Kirikae T, Shimbo T, Lee MC, Yoshino F, Maruoka Y, Itoh T, Ishikawa I, Izumi Y.

BMC Oral Health. 2014 Dec 15;14:152. doi: 10.1186/1472-6831-14-152.

Supplemental Content

Loading ...
Support Center